Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
Cindy FranklinPeter MohrLeonie BluhmFriedegund MeierMarlene GarzarolliMichael WeichenthalKatharina KählerImke GrimmelmannRalf GutzmerJochen UtikalPatrick TerheydenRudolf HerbstSebastian HaferkampClaudia PfoehlerAndrea ForschnerUlrike LeiterFabian ZillerFrank MeissJens UlrichAlexander KreuterChristoffer GebhardtJulia WelzelBastian SchillingMartin KaatzKarin Scharfetter-KochanekEdgar DippelDorothee NashanMichael SachseCarsten WeishauptHarald LöfflerThilo GambichlerCarmen LoquaiLucie HeinzerlingStephan GrabbeDirk DebusGaston SchleyJessica C HasselGerhard WeyandtMaike TrommerGeorg LoddeJan-Malte PlackeLisa ZimmerElisabeth LivingstoneJürgen Christian BeckerSusanne HornDirk SchadendorfSelma UgurelPublished in: Journal for immunotherapy of cancer (2023)
patients, no differences in brain metastasis and survival outcomes were detected for CTLA-4+PD-1 compared with PD-1.